The course presents a review of recent changes in the management of resected NSCLC as well as the management of patients with early stage NSCLC treated with SBRT. The four main topics are:

Radiation is an integral component of the treatment of small cell lung cancer, as a definitive treatment for limited stage disease, as prophylactic cranial irradiation for prevention of brain metastases, as consolidation to the chest in extensive stage disease, and for palliation.

This panel discussion (part 3) presents on overcoming barriers to come for lung cancer, and includes a pulmonologist, a radiation oncologist, a thoracic surgeon, and a medical oncologist.

This panel discussion (part 2) presents on overcoming barriers to come for lung cancer, and includes a pulmonologist, a radiation oncologist, a thoracic surgeon, and a medical oncologist.

This panel discussion (part 1) presents on overcoming barriers to come for lung cancer, and includes a pulmonologist, a radiation oncologist, a thoracic surgeon, and a medical oncologist.

This education activity is aimed at updating participants with the latest available data regarding the use of radiotherapy for patients with metastatic lung cancer. The primary focus will be on the use of radiotherapy with curative intent for patients with limited metastatic disease.

This activity present on the the topic of: Lung SABR for early stage NSCLC, reviewing patient selection, treatment planning, dose-fractionation followed by challenging aspects such as ultra-central lesions and reirradiation, and Locally advanced (Stage III NSCLC), discussing patient selection for

The management of non-small cell lung cancer has undergone major transformation in the last three years driven by the increasing using of immunotherapy as well as local ablative therapies in advanced stage disease.

This is an educational course - a deeper dive on Lung Cancer and it includes video, slides, and audio files from the following sessions presented in 2021: